Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alvotech (ALVO) vs Prestige Consumer Healthcare Inc. (PBH)

Alvotech and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech and Prestige Consumer Healthcare Inc. are of similar size ($2.3B and $2.2B). Alvotech has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.0×. Alvotech grew revenue faster over the last twelve months: 364.3% against −1.36%. Prestige Consumer Healthcare Inc. has the higher net margin (15.6% vs −101.1%) and the higher return on invested capital (4.70% vs 0.00%). Across the 17 metrics below, Prestige Consumer Healthcare Inc. leads on 14 and Alvotech on 3.

Valuation

Metric ALVO PBH Drug Manufacturers Specialty & Generic median
P/E n/m 12.98 20.14
P/S 5.77 2.00 2.25
P/B n/m 1.15 1.90
Price to free cash flow n/m 9.40 16.54
EV/EBITDA n/m 12.82 12.29
EV/Sales 9.74 3.76 2.56
Earnings yield (20.81%) 7.70% (2.99%)
Free cash flow yield (12.51%) 10.64% 0.00%

Profitability

Metric ALVO PBH Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 53.53% 53.94%
Operating margin (42.43%) 26.26% 0.00%
Net margin (101.05%) 15.57% 0.00%
Free cash flow margin 0.00% 21.30% 0.00%
Return on equity 0.00% 9.12% (0.40%)
Return on assets 0.00% 4.30% (3.32%)
Return on invested capital 0.00% 4.70% 0.00%

Growth

Metric ALVO PBH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% (1.36%) 10.01%
EPS growth (last fiscal year) 111.49% (8.86%) —
Revenue growth, 5-year CAGR — 2.91% 6.74%
Net income growth, 5-year CAGR 0.00% 2.93% 0.00%

Health

Metric ALVO PBH Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 1.06 0.05
Current ratio 1.65 3.23 2.31
Net debt to EBITDA 9.71 2.77 0.85

Dividend

Metric ALVO PBH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ALVO PBH Drug Manufacturers Specialty & Generic median
Market cap 2.30b 2.16b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack